Sapient is a purpose-built biomarker discovery lab providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis.
We leverage high-throughput technologies, backed by an advanced biocomputational framework, to rapidly measure and analyze thousands of dynamic biomarkers per sample.
Our methods finally enable efficient, large-scale profiling beyond the genome and deliver new phenotypic insights to understand disease and accelerate drug development.
We know biomarkers can transform drug development, improving approval rates by 2-10x. We’ve spent the last 10 years innovating technologies to scale biomarker discovery lab capacity to identify more novel biomarkers of health, disease, and drug response.
Jain Lab was founded at University of California San Diego with a mission to innovate mass spectrometry (MS) to probe human biology deeper and at population scale. This multi-disciplinary team developed the next-gen MS systems we use today.
Jain Lab was awarded over $30M in Federal, Foundation, and Industry funding to tackle biological questions across diverse disease areas, vaccine development, maternal fetal health, environmental studies, nutritional studies, and drug response studies.
Sapient was founded by the core Jain Lab members upon seeing the potential of its technologies to transform biomedicine. Now, Sapient is one of the largest capacity biomarker discovery labs in the world.
Sapient was awarded a $9.2M grant from the Bill & Melinda Gates Foundation to support studies aimed at identifying biomarkers that can inform novel nutritional, disease-prevention, and disease-treatment interventions. This grant represented an extension of prior funding awarded to Sapient from the Bill & Melinda Gates Foundation in 2020.
Sapient’s high complexity CLIA laboratory received accreditation from the College of American Pathologists (CAP), confirming adherence to stringent CLIA regulations. As a CLIA-certified, CAP-accredited lab, Sapient can support rapid translation of biomarker discoveries to regulated clinical applications, to further accelerate development and deployment of much-needed diagnostics and therapies.
To innovate technologies to deliver insight into human biology, accelerating the diagnosis of disease, the prediction of health outcomes, and the effective treatment of people worldwide.
To realize the promise of a healthier tomorrow, today.
We are more than a service provider; we are your trusted scientific collaborator. Tap our world-leading expertise in metabolomics and multi-omics discovery.
Biomarker data quality is of the utmost importance for confident decision making, particularly when working with complex, dynamic measures. Sapient upholds stringent standards for testing accuracy and results reliability.
We are a team of passionate scientists, clinicians, and engineers, driven by a tireless curiosity to answer the unknowns about human biology. If you are too, we’d love to talk.
10421 Wateridge Circle, Suite 100
San Diego, CA 92121
discover@sapient.bio
858.290.7010
© 2024 Sapient Bioanalytics, LLC. All rights reserved.
SAPIENT, the SAPIENT Logo, ACCELERATE HUMAN DISCOVERY, and SPECIFICITY AT SCALE are trademarks of Sapient Bioanalytics, LLC
